A detailed history of Signature Estate & Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 3,645 shares of AMGN stock, worth $1.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,645
Previous 2,767 31.73%
Holding current value
$1.16 Million
Previous $786,000 44.78%
% of portfolio
0.03%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $230,694 - $280,354
878 Added 31.73%
3,645 $1.14 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $59,420 - $71,727
-221 Reduced 7.4%
2,767 $786,000
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $57,788 - $65,191
226 Added 8.18%
2,988 $860,000
Q2 2023

Jul 19, 2023

BUY
$214.27 - $253.37 $5,999 - $7,094
28 Added 1.02%
2,762 $613,000
Q4 2022

Jan 11, 2023

SELL
$229.03 - $291.01 $1,145 - $1,455
-5 Reduced 0.18%
2,734 $718,000
Q3 2022

Oct 20, 2022

SELL
$224.46 - $253.15 $1,122 - $1,265
-5 Reduced 0.18%
2,739 $618,000
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $692 - $770
3 Added 0.11%
2,744 $667,000
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $18,857 - $20,861
86 Added 3.24%
2,741 $662,000
Q4 2021

Jan 20, 2022

SELL
$198.88 - $227.6 $22,473 - $25,718
-113 Reduced 4.08%
2,655 $598,000
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $23,986 - $28,103
113 Added 4.26%
2,768 $588,000
Q2 2021

Jul 16, 2021

SELL
$233.58 - $259.14 $374,895 - $415,919
-1,605 Reduced 37.68%
2,655 $647,000
Q1 2021

Apr 15, 2021

SELL
$221.91 - $258.6 $221,910 - $258,600
-1,000 Reduced 19.01%
4,260 $1.06 Million
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $207,724 - $247,363
960 Added 22.33%
5,260 $1.21 Million
Q3 2020

Oct 13, 2020

SELL
$234.65 - $260.95 $38,247 - $42,534
-163 Reduced 3.65%
4,300 $1.09 Million
Q2 2020

Jul 21, 2020

BUY
$197.81 - $242.74 $5,538 - $6,796
28 Added 0.63%
4,463 $1.05 Million
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $53,214 - $70,576
-292 Reduced 6.18%
4,435 $899,000
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $209,455 - $269,222
1,107 Added 30.58%
4,727 $1.14 Million
Q3 2019

Oct 09, 2020

SELL
$174.11 - $208.62 $16,366 - $19,610
-94 Reduced 2.53%
3,620 $701,000
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $13,928 - $16,689
-80 Reduced 2.11%
3,714 $719,000
Q2 2019

Oct 09, 2020

SELL
$166.7 - $195.41 $15,669 - $18,368
-94 Reduced 2.42%
3,794 $699,000
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $648,129 - $759,754
3,888 New
3,888 $716,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.